StevePollardMD

PubMed

• Author's response.
  Joseph C Turbyville, Andrew W Winslow, J Wesley Sublett, James L Sublett, Stephen J Pollard
  Annals of Allergy, Asthma & Immunology. 2017-08-01
• 24 citations
  Comparison of systemic reactions in rush, cluster, and standard-build aeroallergen immunotherapy.
  Andrew W. Winslow, Joseph C. Turbyville, J. Wesley Sublett, James L. Sublett, Stephen J. Pollard
  Annals of Allergy, Asthma & Immunology. 2016-11-01

Journal Articles

• Long-term Safety of nebulized formoterol: Results of a twelve-momth open-label clinical trial in COPD  
  Donohue F, Hanania C, Fogarty S, Campbell C, Rinehart M, Denize-Mize, ( PollardSJ-Study Group), Therapeutic Advances in Respiratory Disease, 1/1/2008
• Evaluation of the Safety and Efficacy of Levalbuterol in 2-5 Year Old Patients with Asthma  
  Skoner D, Greos L, Kim K, Roach J, Parsey M, Baumgartner R. for the Xopenex Pediatric Study Group (Pollard SJ-Study Group), Pediatric Pulmonology, 6/1/2005
• Efficacy and Tolerability of Montelukast Alone or in Combination with Loratadine in Seasonal Allergic Rrhinitis: a Multicenter, Ramdomized, Double-blind, Placebo-contr...  
  Nayak A, Philip G, Lu S, Malice MP, Reiss, T Montelukast Fall Rhinitis Investigator Group (Pollard SJ-Study Group), Annals of Allergy, Asthma, & Immunology, 6/1/2002
• Montelukast, a Leukotriene Receptor Antagonist, for the Treatment of Persistent Asthma in Children Aged 2 to 5 Years  
  Knorr B, Franchi L, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, Michele T, Reiss T, Nguyen H, Bratton D, (Pollard SJ-Study Group), Pediatrics, 9/1/2001
• Treatment of Childhood Asthma With Anti-Immunoglobulin E Antibody (Omalizumab)  
  Milgrom H, Berger W, Nayak A, Gupta N, Pollard SJ, McAlary M, Taylor AF, Rohane, P, Pediatrics, 8/1/2001
• Comparison of Fluticasone Propionate-Salmeterol Combination Therapy and Montelukast in Patients Who Are Symptomatic on Short-acting Beta2 Agonists Alone  
  Calhoun W, Nelson H, Nathan R, Pepsin P, Kalberg C, Emmett A, Rickard K, Dorinsky P, (Pollard SJ-Study Group), American Journal of Respiratory and Critical Care Medicine, 1/1/2001
• Efficacy and Safety of Dry Powder Fluticasone Propionate in Children with Persistent Asthma A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study  
  LaForce CF, Pearlman DS, Ruff ME, Silvers W, Weinstein S, Clements D, Brown Alison, Duke S, Harding S, House K, (Pollard SJ-Study Group), Annals of Allergy, Asthma and Immunology, 11/1/2000
• Tri-Nasal Triamcinolone Nasal Spray 200 and 400 ug qd in Patients Suffering from Seasonal Allergic Rhinitis During the Grass Season  
  Rosenthal R, Berger W, Bronsky E, Dockhorn R, Korenblat P, Lampl K, Lumry W, Pollard S, Raphael G, Rohr C, Shapiro G, Valentine M, Wanderer A, Fleming L, LaVallee N, S..., American Journal of Rhinology, 11/1/1998
• Salmeterol Versus Theophylline in the Treatment of Asthma  
  Pollard SJ, Spector SL, Yancey S W, Cox FM, Emmett A, Annals Allergy Asthma Immunology, 5/1/1997
• A One-Week Dose-Ranging Study of Inhaled Salmeterol in Children with Asthma  
  Stephen J. Pollard, MD, Journal of Asthma, 3/1/1997
• Cockroach Allergy in Kentucky: A Comparison of Inner City, Suburban, and Rural Small Town Populations  
  Stephen J. Pollard, MD, Annals of Allergy, 3/1/1994
• Pharmacokinetics of Oxriphylline in a Pediatric Population  
  Kadlec GJ, Sublett JL, Pollard SJ, Jarboe CH, Annals of Allergy, 11/1/1979
• Non-Compliance in Asthmatic Children: A Study of Theophylline Levels in a Pediatric Emergency Room  
  Sublett JL, Pollard SJ, Kadlec GJ, Karibo JM, Annals of Allergy, 8/1/1979
• Theophylline Toxicity in a Child Demonstrating a Change in Kinetics of Elimination  
  Kadlec G L, Pollard S J, Jarboe C H, Sublett J L, Annuals of Allergy, 12/1/1978
• Join now to see all

Abstracts/Posters

• Safety and Efficacy Experience with Rilonacept (IL-1 Trap) in Adolescents with Cryopyrin-Associated Periodic Syndromes (CAPS)
  Throne ML, Pollard SJ, Goldstein S, Hoffman HM, Grimes IM, Stein DR, Weinstein SP, Mellis SJ, American College of Rheumatology Annual Scientific Meeting, 1/1/2008
• Effect of Omalizumab on Pulmonary Function and Symptom Scores in Adolescents with Moderate-Servere Persistent IgE-Mediated Asthma.
  Pollard S J, Maykut B J, Massanari M, Kiawifard F, Zeldin R K, Geba G P, Annals of Allergy, Asthma and Immunology, 1/1/2007
• Effect of Omalizumab on Measures of Control in Adolescents with Moderate-Severe Persistent Asthma.
  Pollard S J et al, Journal of Allergy and Clinical Immunology, 1/1/2007
• Treatment of Childhood Asthma with Anti-Immunoglobulin E Antibody (Omalizumab).
  Stephen J. Pollard, MD, Sixteenth Annual Pediatric Poster Session, Kosair Children's Hospital, Louisville, KY, 9/1/2003
• The Efficacy And Safety Of rhuMAb-E25 (E25) In Children With Allergic Asthma (AA).
  Milgrom H, Pollard S, Nayak A, Berger W, Bensch G, Hampel F, McAlary M, Fick R, Taylor AF, Gupta N, Rohane PW, AAAAI Annual Meeting, San Diego, CA, 3/1/2000
• Tri-Nasal Triamcinolone Acetonide Nasal Spray 200 and 400 ug qd vs. Placebo and asacort Triamcinolone Acetonide Nasal Aerosol 440 ug qd in Patients Suffering from Seas...
  Rosenthal R, Berger W, Bronsky E, Dockhorn R, Korenblat P, Lampl K, Lumry W, Pollard S, Raphael G, Rohr C, Shapiro G, Valentine M, Wanderer A, Fleming L, LaVallee N, S..., Journal of Rhinology, 6/1/1997
• The Acute Chronic Effects of Foradil on Serum Potassium.
  Yegen U, Pollard S, Kreitzer S, Lisberg E, and Della Cioppa G, American Journal of Respiratory and Critical Care Medicine, 4/1/1997
• The Acute Chronic Effect of Foradil on Serum Potassium.
  Yegen U, Pollard S, Kreitzer S, Lisberg E, and Della Cioppa G, American Journal of Respiratory and Critical Care Medicine, 4/1/1997
• "The Safety of Salmeterol in Pediatric Patients as Assessed by 24 Hour Electrocardiogram Monitoring"
  Stephen J. Pollard, MD, University of Louisville, Louisville, KY, 5/1/1995
• "Salmeterol BID is More Effective Than Theophylline BID or PRN Albuterol in Patients With Asthma"
  Stephen J. Pollard, MD, ATS Annual Meeting, Seattle, WA, 5/1/1995
• Salmeterol BID is More Effective Than Theophylline BID or PRN. Albuterol in Patients with Asthma.
  Pollard S J, Lumry W, Diamond E J, Sahn S, Wisniewski M, Rickard K A, Yancey S W, Journal of Respiratory and Critical Care Medicine, 4/1/1995
• The Safety of Salmeterol in Pediatric Patients as Assessed by 24-Hour Electrocardiogram Monitoring.
  Stephen J. Pollard, MD, International Conference of American Thoracic Society, Boston, MA, 5/1/1994
• The Safety of Salmeterol in Pediatric Patients as Assessed by 24-Hour Electrocardiogram Monitoring.
  Pollard S J, Bronsky E A, Chervinsky P, Findlay S R, Liddle R, Brandi V, Bishop A L, Journal of Respiratory and Critical Care Medicine, 4/1/1994
• Patient Instruction Techniques as a Method to Improve Compliance in Asthmatic Children.
  Stephen J. Pollard, MD, Annals of Allergy, 2/1/1979
• Join now to see all

Lectures

• "Understanding Asthma vs COPD" 
  Brandeburg, KY - 11/1/2009
• "Assessing and Managing Asthma Control" 
  Terra Haute, IN - 8/1/2009
• "Assesing and Managing Asthma Control" 
  Abingdon, VA - 9/1/2008
• "Asthma Control, What are The Challenges" 
  Georgetown, KY - 9/1/2008
• Grand Rounds: "Update on NHLBI Asthma Guidelines" 
  UL Dept Family Practice, Louisville, KY - 8/1/2008
• "Role of Anti-IgE Treatment in IgE-Mediated Asthma" 
  Somerset, KY - 6/1/2008
• "Allergic Rhinitis: Local Implications for Clinical Practice" 
  Cynthiana, KY - 6/1/2008
• "Assessing Asthma Control: New Tools and Strategies" 
  Harlan, KY - 5/1/2008
• "Update on NAEPP Guidelines" 
  Barbourville, KY - 5/1/2008
• "Update on NHLBI Asthma Guidelines" 
  Louisville, KY - 5/1/2008
• "Update on NAEPP Guidelines and Role of Symbicort in Asthma Control" 
  Lexington, KY - 2/1/2008
• "Assessing Asthma Control: New Tools and Strategies and Role of Symbicort in Asthma Control" 
  Winchester, KY - 2/1/2008
• "Airway Remodeling and Asthma Disease Progression: Implications for Treatment" 
  Louisville, KY - 11/1/2007
• "NHLBI Asthma Guidelines Update" 
  Newport, KY - 11/1/2007
• "Update on the NAEPP Guidelines and the Role of Symbicort in Asthma Control" 
  Louisville, KY - 8/1/2007
• "The Role of Symbicort in Asthma Control (for Primary Care audiences)" 
  Lexington, KY - 7/1/2007
• "Assessing Asthma Control: New Tools and Strategies and the Role of Symbicort in Asthma Control" 
  Mount Sterling, KY - 7/1/2007
• "The Role of Symbicort in Asthma Control (for Specialty audiences)" 
  Lexington, KY - 6/1/2007
• "A Closer Look at Allergic Rhinitis Symptoms From the Patient's Perspective" 
  Indianapolis, IN - 5/1/2007
• "A Closer Look at Allergic Rhinitis Symptoms From the Patient's Perspective." 
  New Albany, IN - 4/1/2007
• "The Treatment of Difficult-To-Control Asthma With Omalizumab (Xolair)" 
  Louisville, KY - 3/1/2007
• "Heterogeneity in Asthma" 
  Louisville, KY - 3/1/2007
• "Effect of Omalizumab on Measures of Control in Adolescents with Moderate-Severe Persistent Asthma." 
  San Diego, CA - 2/1/2007
• "Xolair Therapy in Allergic Asthma" 
  Louisville, KY - 1/1/2007
• "Effect of Omalizumab on FEV1 and Symptom Scores in Adolescents with Moderate-Severe Persistent IgE-Mediated Asthma." 
  Philadelphia, PA - 11/1/2006
• Join now to see all

Other

• Recognition and Management of Asthmatic Children. 
  Stephen J. Pollard, MD, Louisville Medicine
  4/1/1981
• Comparison of Ipratropium Bromide and Albuterol Sulfate Chlorofluorocarbon metered-dose inhaler and Albuterol Hydrofluoroalkane metered-dose inhaler in a crossover tri... 
  E. R. Bleecker, W. Busse, J. Donohue, S. Garfinkel, T. Lystig, R. C. Manuel, R. Schlenker-Herceg, R. Wise on behalf of the 1012.57 Investigators
  Wake Forest University Center of Genomics and Personalized Medicine, Winston Salem